US Stock MarketDetailed Quotes

Adial Pharmaceuticals (ADIL)

Watchlist
  • 0.2250
  • -0.0020-0.88%
Close Jan 16 16:00 ET
  • 0.2350
  • +0.0100+4.44%
Post 20:01 ET
6.25MMarket Cap-0.38P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adial Pharmaceuticals (ADIL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-20.23%1.76M
-17.69%1.88M
22.89%2.27M
20.27%8.28M
8.80%1.94M
62.86%2.21M
54.82%2.29M
-18.68%1.85M
-36.57%6.89M
-31.32%1.78M
Selling and administrative expenses
5.35%1.24M
-9.75%1.15M
9.32%1.52M
-10.06%5.06M
-20.37%1.21M
2.52%1.18M
21.69%1.27M
-26.92%1.39M
-36.91%5.62M
-26.44%1.52M
-General and administrative expense
5.35%1.24M
-9.75%1.15M
9.32%1.52M
-10.06%5.06M
-20.37%1.21M
2.52%1.18M
21.69%1.27M
-26.92%1.39M
-36.91%5.62M
-26.44%1.52M
Research and development costs
-49.49%521.07K
-27.67%732.32K
64.41%746.89K
154.86%3.23M
176.36%730.79K
398.07%1.03M
135.53%1.01M
24.25%454.28K
-35.03%1.27M
-50.28%264.44K
Operating profit
20.23%-1.76M
17.69%-1.88M
-22.89%-2.27M
-20.27%-8.28M
-8.80%-1.94M
-62.86%-2.21M
-54.82%-2.29M
18.68%-1.85M
36.57%-6.89M
31.32%-1.78M
Net non-operating interest income expense
-5.59%47.86K
-53.80%23.75K
55.02%35.35K
156.04%178.66K
378.91%53.76K
395.25%50.69K
164.61%51.4K
-21.08%22.8K
10.17%69.78K
-76.53%11.23K
Non-operating interest income
-5.59%47.86K
-53.80%23.75K
55.02%35.35K
156.04%178.66K
378.91%53.76K
395.25%50.69K
164.61%51.4K
-21.08%22.8K
10.17%69.78K
-76.53%11.23K
Other net income (expense)
-149.60%-77.43K
55.23%-99.59K
100.07%3.15K
-2,671.39%-5.09M
-39.44%-183.82K
-31.02K
-328.65%-222.47K
-4.65M
-183.72K
-131.82K
Gain on sale of security
----
----
----
----
----
----
----
---4.46M
----
----
Earnings from equity interest
-147.95%-76.92K
55.62%-98.73K
14.10%-163.09K
-184.80%-552.18K
---108.82K
---31.02K
---222.47K
---189.87K
---193.88K
----
Special income (charges)
--0
----
----
---4.46M
--0
--0
----
----
--0
--0
-Less:Other special charges
----
----
----
--4.46M
--0
----
----
----
----
----
Other non- operating income (expenses)
---513
---861
395,900.00%166.24K
-838.47%-75.04K
-220.84%-75K
----
----
---42
--10.16K
--62.06K
Income before tax
18.17%-1.79M
20.33%-1.96M
65.59%-2.23M
-88.48%-13.2M
-8.74%-2.07M
-62.63%-2.19M
-62.82%-2.46M
-189.15%-6.48M
35.14%-7M
25.31%-1.9M
Income tax
0
0
0
0
0
0
0
Net income
18.17%-1.79M
20.33%-1.96M
65.59%-2.23M
-157.59%-13.2M
-7.83%-2.07M
-58.26%-2.19M
-325.99%-2.46M
-122.88%-6.48M
59.76%-5.12M
33.01%-1.92M
Net income continuous Operations
18.17%-1.79M
20.33%-1.96M
65.59%-2.23M
-88.48%-13.2M
-8.74%-2.07M
-62.63%-2.19M
-62.82%-2.46M
-189.15%-6.48M
35.14%-7M
25.31%-1.9M
Net income discontinuous operations
----
----
----
--0
--0
--0
--0
--0
197.07%1.88M
94.99%-15.9K
Minority interest income
Net income attributable to the parent company
18.17%-1.79M
20.33%-1.96M
65.59%-2.23M
-157.59%-13.2M
-7.83%-2.07M
-58.26%-2.19M
-325.99%-2.46M
-122.88%-6.48M
59.76%-5.12M
33.01%-1.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
18.17%-1.79M
20.33%-1.96M
65.59%-2.23M
-157.59%-13.2M
-7.83%-2.07M
-58.26%-2.19M
-325.99%-2.46M
-122.88%-6.48M
59.76%-5.12M
33.01%-1.92M
Basic earnings per share
78.95%-0.08
69.49%-0.18
84.47%-0.34
24.44%-2.72
87.01%-0.15
67.80%-0.38
-161.46%-0.59
20.36%-2.19
71.68%-3.6
58.32%-1.1544
Diluted earnings per share
78.95%-0.08
69.49%-0.18
84.47%-0.34
24.44%-2.72
87.01%-0.15
67.80%-0.38
-161.46%-0.59
20.36%-2.19
71.68%-3.6
58.32%-1.1544
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -20.23%1.76M-17.69%1.88M22.89%2.27M20.27%8.28M8.80%1.94M62.86%2.21M54.82%2.29M-18.68%1.85M-36.57%6.89M-31.32%1.78M
Selling and administrative expenses 5.35%1.24M-9.75%1.15M9.32%1.52M-10.06%5.06M-20.37%1.21M2.52%1.18M21.69%1.27M-26.92%1.39M-36.91%5.62M-26.44%1.52M
-General and administrative expense 5.35%1.24M-9.75%1.15M9.32%1.52M-10.06%5.06M-20.37%1.21M2.52%1.18M21.69%1.27M-26.92%1.39M-36.91%5.62M-26.44%1.52M
Research and development costs -49.49%521.07K-27.67%732.32K64.41%746.89K154.86%3.23M176.36%730.79K398.07%1.03M135.53%1.01M24.25%454.28K-35.03%1.27M-50.28%264.44K
Operating profit 20.23%-1.76M17.69%-1.88M-22.89%-2.27M-20.27%-8.28M-8.80%-1.94M-62.86%-2.21M-54.82%-2.29M18.68%-1.85M36.57%-6.89M31.32%-1.78M
Net non-operating interest income expense -5.59%47.86K-53.80%23.75K55.02%35.35K156.04%178.66K378.91%53.76K395.25%50.69K164.61%51.4K-21.08%22.8K10.17%69.78K-76.53%11.23K
Non-operating interest income -5.59%47.86K-53.80%23.75K55.02%35.35K156.04%178.66K378.91%53.76K395.25%50.69K164.61%51.4K-21.08%22.8K10.17%69.78K-76.53%11.23K
Other net income (expense) -149.60%-77.43K55.23%-99.59K100.07%3.15K-2,671.39%-5.09M-39.44%-183.82K-31.02K-328.65%-222.47K-4.65M-183.72K-131.82K
Gain on sale of security -------------------------------4.46M--------
Earnings from equity interest -147.95%-76.92K55.62%-98.73K14.10%-163.09K-184.80%-552.18K---108.82K---31.02K---222.47K---189.87K---193.88K----
Special income (charges) --0-----------4.46M--0--0----------0--0
-Less:Other special charges --------------4.46M--0--------------------
Other non- operating income (expenses) ---513---861395,900.00%166.24K-838.47%-75.04K-220.84%-75K-----------42--10.16K--62.06K
Income before tax 18.17%-1.79M20.33%-1.96M65.59%-2.23M-88.48%-13.2M-8.74%-2.07M-62.63%-2.19M-62.82%-2.46M-189.15%-6.48M35.14%-7M25.31%-1.9M
Income tax 0000000
Net income 18.17%-1.79M20.33%-1.96M65.59%-2.23M-157.59%-13.2M-7.83%-2.07M-58.26%-2.19M-325.99%-2.46M-122.88%-6.48M59.76%-5.12M33.01%-1.92M
Net income continuous Operations 18.17%-1.79M20.33%-1.96M65.59%-2.23M-88.48%-13.2M-8.74%-2.07M-62.63%-2.19M-62.82%-2.46M-189.15%-6.48M35.14%-7M25.31%-1.9M
Net income discontinuous operations --------------0--0--0--0--0197.07%1.88M94.99%-15.9K
Minority interest income
Net income attributable to the parent company 18.17%-1.79M20.33%-1.96M65.59%-2.23M-157.59%-13.2M-7.83%-2.07M-58.26%-2.19M-325.99%-2.46M-122.88%-6.48M59.76%-5.12M33.01%-1.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 18.17%-1.79M20.33%-1.96M65.59%-2.23M-157.59%-13.2M-7.83%-2.07M-58.26%-2.19M-325.99%-2.46M-122.88%-6.48M59.76%-5.12M33.01%-1.92M
Basic earnings per share 78.95%-0.0869.49%-0.1884.47%-0.3424.44%-2.7287.01%-0.1567.80%-0.38-161.46%-0.5920.36%-2.1971.68%-3.658.32%-1.1544
Diluted earnings per share 78.95%-0.0869.49%-0.1884.47%-0.3424.44%-2.7287.01%-0.1567.80%-0.38-161.46%-0.5920.36%-2.1971.68%-3.658.32%-1.1544
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -